Keyphrases
Tumor
82%
α-emitter
57%
Mutant p53
53%
Radiation Therapy
46%
224Ra
36%
Alpha Particles
32%
Extracellular Vesicles
32%
Inflammation
28%
Tumor Microenvironment
27%
Cancer Cells
27%
Squamous Cell Carcinoma (SqCC)
22%
Tumor Protein p53 (TP53)
21%
Chemotherapy
19%
Macrophages
18%
Lung Cancer
18%
Acidovorax
18%
Tumor Growth
17%
Human Lung Cancer
16%
Microbiome
16%
Tumor-associated Macrophages
15%
TP53 mutation
13%
Exosomes
13%
Chronic Inflammation
13%
Radium-224
13%
Colorectal Cancer
12%
Tumor Cells
12%
Lung
12%
Solid Tumor Therapy
12%
TP53 Gene
11%
Solid Tumors
11%
Inflammation-associated Cancer
10%
Local Control
10%
Tumor Tissue
10%
Head-and-neck Cancer
10%
Brachytherapy
10%
Metastasis
8%
MiR-1246
8%
Immune Regulation
8%
K-ras
8%
Growth Retardation
7%
Tumor Development
7%
Mutant p53 Gain of Function
7%
Radiotherapy
7%
Cancer Progression
7%
Alpha Radiation
6%
Non-cell Autonomous
6%
P53 Isoforms
6%
Dosimetric Analysis
6%
Tumor Survival
6%
Diversity Arrays Technology (DArT)
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Radium 224
42%
Malignant Neoplasm
31%
Protein P53
22%
Solid Malignant Neoplasm
22%
Squamous Cell Carcinoma
22%
Mouse
21%
Chemotherapy
19%
Lung Cancer
16%
Immunotherapy
14%
Tumor Growth
11%
Microbiome
11%
Inflammation
10%
Radon 220
9%
Acidovorax
9%
Lead 212
9%
Nude Mouse
7%
Growth Retardation
7%
Microflora
7%
Tumor Microenvironment
6%
Dosimetry
6%
Glioblastoma
6%
Experimental Colon Cancer
5%
Head and Neck Cancer
5%
Pancreas Tumor
5%
Bevacizumab
5%
Temozolomide
5%
Chimeric Antigen Receptor
5%
Medicine and Dentistry
Neoplasm
46%
Lung Cancer
16%
Radium 224
15%
Radiation Therapy
12%
Cancer Cell
11%
Cancer Therapy
11%
Microbiome
11%
Immunotherapy
10%
In Vitro
9%
Malignant Neoplasm
9%
Brachytherapy
8%
Tumor Microenvironment
7%
Solid Malignant Neoplasm
7%
Acidovorax
7%
Diseases
6%
Homeostasis
6%
Cancer
6%
Gut
5%
Classical Hodgkin Lymphoma
5%
Radon 220
5%
Pancreas Tumor
5%
Symbiont
5%
DNA Damage
5%
DNA Repair
5%
Immunohistochemistry
5%
4 Iodo 2,5 Dimethoxyamphetamine
5%
Antiinflammatory Activity
5%
Disease
5%
Tumor Immune Microenvironment
5%
Embryo Development
5%
Cellular Senescence
5%
Treatment Planning
5%
Lymphoma Cell
5%
Aggression
5%
Biocompatible Material
5%
Chimeric Antigen Receptor
5%
Radiation Therapy
5%
Langerhans Cell Histiocytosis
5%
Bifidobacterium longum
5%
Cell Death
5%
Head and Neck Cancer
5%
